Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma — NTG-X-PERT

Low Tension Glaucoma Clinical Trial

Official title:
Prospective, Observational Study to Investigate the Long-term Effect of Xalatan® on Intraocular Pressure (IOP) and on Maintenance of Visual Field in Patients With Normal Tension Glaucoma (NTG)

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the long-term efficacy and safety of latanoprost monotherapy in patients with normal tension glaucoma (NTG) using a prospective, observational design. Visits were scheduled at 6-month intervals for 24 months. Intraocular pressure (IOP), optic nerve head findings, visual field status, and adverse events were recorded.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01209624
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase
Start date	August 2006
Completion date	September 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01487655` - Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients	N/A
Terminated	`NCT02891317` - Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
Recruiting	`NCT03098316` - Metabolomics in Surgical Ophthalmological Patients	N/A
Completed	`NCT01391247` - Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation	N/A
Active, not recruiting	`NCT03391518` - Evaluation of Blood Flow Regulation With Laser Speckle Flowgraphy	N/A